학술논문
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Han, MeiLan K ; Antila, Martti; Ficker, Joachim H; Gordeev, Ivan; Guerreros, Alfredo; Bernus, Amparo Lopez; Roquilly, Antoine; Sifuentes-Osornio, José; Tabak, Fehmi; Teijeiro, Ricardo; Bandelli, Lorraine; Bonagura, Diane S; Shu, Xu; Felser, James M; Knorr, Barbara; Cao, Weihua; Langmuir, Peter; Lehmann, Thomas; Levine, Michael; Savic, Sinisa
Source
In The Lancet Rheumatology May 2022 4(5):e351-e361
Subject
Language
ISSN
2665-9913